Interferon-α Revisited: Individualized Treatment Management Eased the Selective Pressure of Tyrosine Kinase Inhibitors on BCR-ABL1 Mutations Resulting in a Molecular Response in High-Risk CML Patients

Bone marrow transplantation or ponatinib treatment are currently recommended strategies for management of patients with chronic myeloid leukemia (CML) harboring the T315I mutation and compound or polyclonal mutations. However, in some individual cases, these treatment scenarios cannot be applied. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Polivkova, Vaclava, Rohon, Peter, Klamova, Hana, Cerna, Olga, Divoka, Martina, Curik, Nikola, Zach, Jan, Novak, Martin, Marinov, Iuri, Soverini, Simona, Faber, Edgar, Machova Polakova, Katerina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877000/
https://www.ncbi.nlm.nih.gov/pubmed/27214026
http://dx.doi.org/10.1371/journal.pone.0155959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877000/
https://www.ncbi.nlm.nih.gov/pubmed/27214026
http://dx.doi.org/10.1371/journal.pone.0155959

Ejemplares similares